Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.04.367359Source: DataRank Database

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (26)IDs (PubMed)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Wen‐Hsiang Chen ORCID,Leroy Versteeg ORCID,Brian Keegan ORCID,Bin Zhan ORCID,Junfei Wei ORCID

Live enrichment

PubMed:23304386

National Institutes of Health

Grant: 3P30CA125123-09S3

Baylor College of Medicine Cancer Center

greenLicense: https://www.biorxiv.org/about/FAQ#license

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/02/09/2020.11.04.367359.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.11.04.367359

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7654852

https://doi.org/10.1101/2020.11.04.367359

https://doi.org/10.1080/21645515.2021.1901545

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

COVID-19 VaccinesT-LymphocytescoronavirusRM1-950Saccharomyces cerevisiaeace-2Antibodies, ViralMiceProtein DomainsAnimalsHumansMice, Inbred BALB CpseudovirusSARS-CoV-2COVID-19RC581-607Antibodies, NeutralizingrbdalumSaccharomycetalesSpike Glycoprotein, CoronavirusTherapeutics. PharmacologyImmunologic diseases. AllergyResearch Paper

Sustainable Development Goals

SDG 3: 3. Good health

SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice

FAIR Checklist

Authors (20)

Funding (1 grants)

Open Access

Topics

Annotations (Europe PMC)